1. Home
  2. PLSE vs ABCL Comparison

PLSE vs ABCL Comparison

Compare PLSE & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$13.86

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$2.77

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
ABCL
Founded
2014
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
PLSE
ABCL
Price
$13.86
$2.77
Analyst Decision
Buy
Buy
Analyst Count
1
5
Target Price
$22.00
$7.75
AVG Volume (30 Days)
162.7K
5.0M
Earning Date
02-19-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$86,000.00
$35,325,000.00
Revenue This Year
N/A
$25.45
Revenue Next Year
$1,057.59
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.17
52 Week Low
$12.56
$1.89
52 Week High
$25.00
$6.52

Technical Indicators

Market Signals
Indicator
PLSE
ABCL
Relative Strength Index (RSI) 46.16 26.80
Support Level $13.44 $3.92
Resistance Level $15.25 $3.69
Average True Range (ATR) 0.80 0.30
MACD -0.00 -0.15
Stochastic Oscillator 23.10 2.38

Price Performance

Historical Comparison
PLSE
ABCL

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: